Subcutaneous adipose tissue insulin resistance and lipolysis in patients with nonalcoholic steatohepatitis

Subcutaneous adipose tissue insulin resistance and lipolysis in patients with nonalcoholic steatohepatitis

Detalhes bibliográficos
Main Authors:	Armstrong, M, Hazlehurst, J, Hull, D, Borrows, S, Guo, K, Yu, J, Barton, D, Gaunt, P, Gough, S, Tomlinson, J, Newsome, P
Formato:	Conference item
Publicado em:	2013

Registos relacionados

Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
Por: Armstrong, M, et al.
Publicado em: (2014)

Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis.
Por: Armstrong, M, et al.
Publicado em: (2014)

Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial
Por: Armstrong, M, et al.
Publicado em: (2013)

Glucocorticoids fail to cause insulin resistance in human subcutaneous adipose tissue in vivo.
Por: Hazlehurst, J, et al.
Publicado em: (2013)

Orlistat for overweight subjects with nonalcoholic steatohepatitis.
Por: Dowman, J, et al.
Publicado em: (2009)

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.
Por: Armstrong, M, et al.
Publicado em: (2015)

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
Por: Armstrong, M, et al.
Publicado em: (2013)

Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue.
Por: Samra, J, et al.
Publicado em: (1998)

Effects of morning rise in cortisol concentration on regulation of lipolysis in subcutaneous adipose tissue.
Por: Samra, J, et al.
Publicado em: (1996)

Glucocorticoid modulation of insulin signaling in human subcutaneous adipose tissue.
Por: Gathercole, L, et al.
Publicado em: (2007)

Suppression of the nocturnal rise in growth hormone reduces subsequent lipolysis in subcutaneous adipose tissue.
Por: Samra, J, et al.
Publicado em: (1999)

Ex vivo Analysis of Lipolysis in Human Subcutaneous Adipose Tissue Explants
Por: Pauline Decaunes, et al.
Publicado em: (2018-02-01)

Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis
Por: Hegazy MA, et al.
Publicado em: (2019-07-01)

Anti-Lipolysis Induced by Insulin in Diverse Pathophysiologic Conditions of Adipose Tissue
Por: Zhao J, et al.
Publicado em: (2020-05-01)

Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle.
Por: Dowman, J, et al.
Publicado em: (2014)

Necroptosis in Nonalcoholic Steatohepatitis
Por: Jérémie Gautheron, PhD, et al.
Publicado em: (2015-05-01)

Short- and long-term glucocorticoid treatment enhances insulin signalling in human subcutaneous adipose tissue.
Por: Gathercole, L, et al.
Publicado em: (2011)

Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men.
Por: Jocken, J, et al.
Publicado em: (2008)

Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure
Por: Lim, T, et al.
Publicado em: (2018)

Lipopolysaccharide induces lipolysis and insulin resistance in adipose tissue from dairy cows
Por: Miguel Chirivi, et al.
Publicado em: (2022-01-01)

Etiopathogenesis of Nonalcoholic Steatohepatitis: Role of Obesity, Insulin Resistance and Mechanisms of Hepatotoxicity
Por: Praveen Guturu, et al.
Publicado em: (2012-01-01)

Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
Por: Mazen Noureddin, et al.
Publicado em: (2020-10-01)

Regional and gender variations in adipose tissue lipolysis in response to weight loss
Por: P. Mauriège, et al.
Publicado em: (1999-09-01)

Effect of beta-adrenergic stimulation on whole-body and regional abdominal subcutaneous adipose tissue lipolysis in lean and obese men
Por: Jocken, J, et al.
Publicado em: (2007)

Changes in adipose tissue lipolysis gene expression and insulin sensitivity after weight loss
Por: Monika Karczewska-Kupczewska, et al.
Publicado em: (2020-02-01)

The Molecular Brakes of Adipose Tissue Lipolysis
Por: Yongguo Li, et al.
Publicado em: (2022-02-01)

Stimulation of lipolysis in adipose tissue in vitro by inhibitors of lipid mobilization
Por: F.P. Kupiecki, et al.
Publicado em: (1970-01-01)

Role of Subcutaneous Adipose Tissue in the Pathogenesis of Insulin Resistance
Por: Pavankumar Patel, et al.
Publicado em: (2013-01-01)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Por: Dowman, J, et al.
Publicado em: (2011)

Nonalcoholic Steatohepatitis: An Evolving Diagnosis
Por: Brent A Neuschwander-Tetri
Publicado em: (2000-01-01)

Oligonucleotide therapies for nonalcoholic steatohepatitis
Por: Sixu Li, et al.
Publicado em: (2024-06-01)

Challenges and opportunities in nonalcoholic steatohepatitis
Por: Wang Xiaobo
Publicado em: (2022-08-01)

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
Por: Anca Smaranda Farmazon, et al.
Publicado em: (2018-09-01)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
Por: Gopanandan Parthasarathy, et al.
Publicado em: (2020-04-01)

The metabolic basis of nonalcoholic steatohepatitis
Por: Manu V. Chakravarthy, et al.
Publicado em: (2020-10-01)

Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis
Por: S.M. Touhidul Islam, et al.
Publicado em: (2020-09-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Por: Melanie D Beaton
Publicado em: (2012-01-01)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
Por: Mindy C.W. Lam, et al.
Publicado em: (2012-07-01)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
Por: Helma P. Cotrim, et al.
Publicado em: (2016-05-01)

Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic SteatohepatitisSummary
Por: Mikhaïl A. Van Herck, et al.
Publicado em: (2020-01-01)